2004
DOI: 10.1016/j.bbrc.2004.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Anti-HCV activities of selective polyunsaturated fatty acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
77
0
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 97 publications
(85 citation statements)
references
References 23 publications
7
77
0
1
Order By: Relevance
“…Analyzing the effect of hexanic extracts from seeds against both viruses it seems to confirm the interaction between virus and PUFAs reported in the literature (Apostolov et al, 1989;Leu et al 2004;Orhan et al, 2011). For example, the pretreatment of cells with extracts having oleic and linoleic acid as major compounds, lead to maximal antiviral effect against hepatitis C virus (HCV) (Oh and Chung, 2014).…”
Section: Discussionsupporting
confidence: 79%
“…Analyzing the effect of hexanic extracts from seeds against both viruses it seems to confirm the interaction between virus and PUFAs reported in the literature (Apostolov et al, 1989;Leu et al 2004;Orhan et al, 2011). For example, the pretreatment of cells with extracts having oleic and linoleic acid as major compounds, lead to maximal antiviral effect against hepatitis C virus (HCV) (Oh and Chung, 2014).…”
Section: Discussionsupporting
confidence: 79%
“…The maximal effects of 2-AG and AA were obtained with 3 μM 2-AG or AA, which inhibited the growth of S. aureus and E. coli by ~95% and ~85%, respectively. Importantly, the low concentration of LTB 4 , AA, or 2-AG that we used did not impact virus infectivity or bacterial growth [48,49].…”
Section: -Ag and Aa Induce The Release Of Antimicrobial Effectors Bymentioning
confidence: 98%
“…It is also expected that bisphosphonate has antiviral effects because bisphosphonate inhibits farnesyl-diphosphate synthase, the expression of which was enhanced in HCV-infected liver. Furthermore, eicosapentaenoic acid (EPA) was reported to inhibit HCV replication in the replicon system and to suppress SREBP-1c activity (19,20). Therefore, EPA might elicit antiviral effects via the inhibition of SREBP-1c.…”
Section: Discussionmentioning
confidence: 99%